1.Minimally Invasive Lumbar Microdiscectomy using Tubular Retractor: A Preliminary Report.
Yung PARK ; Joong Won HA ; Hyun Cheol OH ; Ju Hyung YOO ; Yun Tae LEE ; Doo Hyung LEE ; Chul Jun CHOI
The Journal of the Korean Orthopaedic Association 2005;40(6):679-685
PURPOSE: To evaluate the early clinical results of lumbar microdiscectomy using minimally invasive tubular retractor (METRx-MD system, Medtronic Sofamor Danek, Memphis, TN), and to validate the merits of minimally invasive spinal surgery. MATERIALS AND METHODS: From April, 2003 to April 2004 we retrospectively studied a consecutive series of 45 patients who underwent lumbar microdiscectomy using minimally invasive tubular retractor. In all cases, minimally invasive approach using the tubular retractor were performed with a 2 cm sized paramedian incision. The following data were collected: clinical outcomes, operative time, intraoperative blood loss, need for blood replacement, time needed before ambulation, length of hospital stay, and complications. The clinical outcomes were assessed by the modified MacNab criteria. RESULTS: Minimally invasive tubular microdiscectomy was performed in 45 patients over a 12-month period with an average follow-up of approximately 8 months. The clinical outcomes assessed by MacNab criteria were excellent in 33 patients (73%), good in 10 patients (22%). The average operative time was 63 minutes (range, 35 to 95 minutes). The average blood loss was 62 mL (range, 50 to 110 mL). None of the patients needed blood replacement. With the exception of 2 patients, all patients could walk at the day of surgery. The average hospital stay was 2.3 days. None of the patients had dural tear, wound problem, or other complications. CONCLUSION: Lumbar microdiscectomy using tubular retractor can offer a useful modality for the treatment of lumbar herniated disc with the merits of minimally invasive spinal surgery. Further long-term, randomized, prospective investigations are needed to fully evaluate the impact of this technique.
Follow-Up Studies
;
Humans
;
Intervertebral Disc Displacement
;
Length of Stay
;
Operative Time
;
Wounds and Injuries
2.Effects of DCA on Cell Cycle Proteins in Colonocytes.
Journal of the Korean Society of Coloproctology 2010;26(4):254-259
PURPOSE: Evidence that indicates bile acid is a promoter of colon cancer exists. Deoxycholic acid (DCA) modifies apoptosis or proliferation by affecting intracellular signaling and gene expression. However, because previous studies have been based on studies on colon cancer cell lines, the effect of DCA on normal colonocytes is unknown. METHODS: Normal colonocytes and Caco-2 and HCT116 cells were treated with 20 micrometer and 250 micrometer of DCA, and the effect of different concentrations of DCA was measured based on the expression of cell-cycle-related proteins by using Western blots. RESULTS: The expressions of CDK2 and cyclin D1 for different concentrations of DCA in normal colonocytes and colon cancer cells were similar, but the expressions of cyclin E and A were significantly different. In HCT116 colon cancer cells, the expression of cyclin E increased regardless of the DCA concentration, but in normal colonocytes and Caco-2 cells, the expression of cyclin E was not changed or decreased. In HCT116 colon cancer cells, the expression of cyclin A was not changed or decreased regardless of the DCA concentration, but in normal colonocytes and Caco-2 cells, the expression of cyclin A was increased at a DCA concentration of 20 micrometer. CONCLUSION: The effect of DCA on stimulating cell proliferation suggests that DNA synthesis is stimulated by an increased expression of cyclin E in colon cancer cells. Our results suggest that a low dose of DCA induces cellular proliferation through increased expression of cyclin A and that a high dose of DCA induces decreased expression of cyclin E and CDK2 in normal colonocytes.
Apoptosis
;
Bile
;
Blotting, Western
;
Caco-2 Cells
;
Cell Cycle
;
Cell Cycle Proteins
;
Cell Line
;
Cell Proliferation
;
Colonic Neoplasms
;
Cyclin A
;
Cyclin D1
;
Cyclin E
;
Cyclins
;
Deoxycholic Acid
;
DNA
;
Gene Expression
;
HCT116 Cells
;
Humans
;
Proteins
3.Combination Chemotherapy with High Dose Cisplatin - Cyclophosphamide in Primary Epithelial Ovarian Cancer.
Jeong Sup YUN ; Ha Jeong KIM ; Sung Kyoo JANG ; Ki Hyung KIM ; Man Soo YOON
Korean Journal of Gynecologic Oncology and Colposcopy 2001;12(1):12-22
OBJECTIVE: The purpose of this study was to evaluate the therapeutic efficacy and toxicity of high dose cisplatin-cyclophosphamide combination chemotherapy on patients with primary epithelial ovarian cancer. METHODS: A review of 63 patients previously diagnosed as primary epithelial ovarian cancer after initial operation and histology at Pusan National University Hospital from Jul. 1993 to Jun, 1997 was performed. Patients were received the combination chemotherapy including cisplatin 100mg/m2/day and cyclophosphamide 750mg/m2/day, repeated 6 cycles every 4 weeks. The mean age was 48 years old, and previous surgical procedures were total abdominal hysterectomy and bilateral salpingo-oophorectomy with omentectomy. The patients were classified into FIGO stage and pathologic results. RESULTS: The clinical response rate was 100% in the FIGO stage Ic patients with PC combination chemotherapy, 100% in stage II, 53.5% in stage III, and 25% in stage IV. The overall response rate was 69.8%. The 3-year survival rate according to the treatment groups was 93.3% in stage Ic group, 60% in stage II, 50% in stage III and 0% in stage IV. The mean survival duration was 34.6 months. Hematologic toxicities in cisplatin-cyclophosphamide chemotherapy were neutropenia and anemia. Nausea and vomiting were the most common side effects and occurred in 96.8%. Most of the toxicities were grade 1 and 2. CONCLUSION: The combination chemotherapy with cisplatin-cyclophosphamide is relatively safe and effective method in the treatment of primary epithelial ovarian cancer.
Anemia
;
Busan
;
Cisplatin*
;
Cyclophosphamide*
;
Drug Therapy
;
Drug Therapy, Combination*
;
Humans
;
Hysterectomy
;
Middle Aged
;
Nausea
;
Neutropenia
;
Ovarian Neoplasms*
;
Survival Rate
;
Vomiting
4.A Clinical Observation of Non-Union of Trochanter
Key Yong KIM ; Duck Yun CHO ; Hyung Ku YOON ; Eung Ha KIM
The Journal of the Korean Orthopaedic Association 1987;22(1):192-200
The trochanteric fracture occurs through the wide metaphyseal area, giving it high potential for healing and results in low incidence of non union. Even in the treatment of unstable trochanteric fracture, the results are relatively good with the advancement of fixation devices and reduction methods. The authors experienced 10 cases of non-union of trochanteric fractures from 1975 to 1984 and followed them up for more than 1 year at Orthopaedic department of National Medical Center. The results are as follows, l. Of reduction methods in primary operation, anatomical reduction was performed in 6 cases, medialization in 2 cases. Of fixation devices, compression hip screw was used in 2 cases, Jewett nail in 3 cases and others in 3 cases. 2. The probable causes of non-union were fixation failure in 6 cases, inadequate immobilization in 2 cases, infection in 2 cases and trauma in 1 case. The other 2 cases were not treated. 3. In secondary operation, anatomical reduction was performed in 3 cases, valgus reduction in 3 cases and valgus with medialization in 2 cases. Of fixation devices, compression hip screw was used in 3 cases, Judet plate in 3 cases and Jewett nail in Z cases. 4. The time interval between the last operation and bony union was 4.2 months clinically and 6.6 months radiologically in average. 5. During follow-up, hip pain was noted in 2 cases. Limited range of motion of hip and knee in 4 cases.
Femur
;
Follow-Up Studies
;
Hip
;
Hip Fractures
;
Immobilization
;
Incidence
;
Knee
;
Range of Motion, Articular
5.The Changes of Serologic Markers in Pneumoconiosis of Coal Workers.
Kwang Ha YOO ; Ho Sang YUN ; Sang Yeup LEE ; Choon Jo JIN ; Cheol Min AHN ; Hyung Joong KIM
Tuberculosis and Respiratory Diseases 2001;50(5):615-623
BACKGROUND: Pneumoconiosis is a parenchymal lung disease that results from the accumulation of coal dust in the lungs and the consequent tissue reaction. To evaluate the role of various personal factors in pneumoconosis and the significance of some serologic markers for assessing the disease activity related to pneumoconiosis, the Rheumatoid Factor(RF), α1-AT, C-Reactive Protein(CRT), ceruloplasmin and fibrinogen levels were measured. METHOD: All the patients were males, 45-76 years old, and the mean duration of coal dust exposure was 23.2 years. 51 patients were classified as having Simple Pneumoconiosis (SP), 59 had Progressive Massive Fibrosis (PMF). Fifty eight men with ages ranging from 26-70 years wer used as normal controls. The serum RF and CRT were titrated using an Autochemistry analyzer (HITACHI 7150 : Japan) and the α1-AT and ceruloplasmin levels were measured using a Nephelometer (Behring Nephelometer : Germany) and the fibrinogen levels were estimated by using and Autoanalyzer for hematologic coagulation. RESULT: There was a higher RF level in the SP, and PMF groups than in the control groups but there was no statistical difference. The CRP, α1-AT, and ceruloplasmin levels were also higher in the SP, and PMF groups. However, the fibrinogen concentration was within the normal ranges in both the SP and PMF groups. CONCLUSION: The CWP (Ed note : Define CWP) patients had significantly higher CRP, α1-AT, and ceruloplasmin levels compared to the control group. It is believed that these serologic changes could be used as a marker of the disease activity.
C-Reactive Protein
;
Ceruloplasmin
;
Coal*
;
Dust
;
Fibrinogen
;
Fibrosis
;
Humans
;
Lung
;
Lung Diseases
;
Male
;
Pneumoconiosis*
;
Reference Values
;
Rheumatoid Factor
6.A Study on Epidemiological Factors of Burn Patients in Emergency Rooms
Sung Tae JUNG ; Chul Min HA ; Hyung Ju LEE ; Young Yun JUNG
Journal of Korean Burn Society 2020;23(2):42-53
Purpose:
It is important to consider both clinical factors and epidemiological factors in treating burn patients in emergency rooms. However, many emergency medical staffs happen to miss their chances of treating burns based on these considerations. This study is designed to find a better treatment for burn patients in emergency rooms along this approach.
Methods:
This study was conducted based on the data of the burn patients visiting the emergency room of a single general hospital from January 2015 to December 2019. The epidemiological and clinical factors were extracted out of the data, then the relationship between the prognosis and these factors were analyzed.
Results:
Most of burn accidents occurred at home, and were caused by hot water, soup, drinks, oil, etc. Especially, flame burns showed high hospitalization rate, surgical rate and mortality. In addition, their prognosis was poor when the affected area included facial, limb and perineal areas etc., or any inhalation burn co-existed. Also, the hospitalization rate and period increased when the treatment time was delayed or the pre-treatment was taken. There was a strong relationship between prognosis and the period of follow-up when patients were admitted during the period.
Conclusion
It is difficult for medical staffs to evaluate prognosis of burns in emergency rooms due to progressive damages.Precise treatment and disposition are essential for patients’ good prognosis. Therefore, medical staffs should establish treatment plans by identifying the patient’s epidemiological and clinical factors, rather than giving prescriptions based on fragmentary and superficial symptoms.
7.Change of Stratification of Three Dimensional Culture by Gingival Keratinocytes & Fibroblasts.
Tae Heup JUNG ; Ha Na HYUN ; Yun Sang KIM ; Eun Cheol KIM ; Hyung Keun YOU ; Hyung Shik SHIN
The Journal of the Korean Academy of Periodontology 2002;32(1):129-142
Epithelial-mesenchymal interaction plays a important role in cell growth and differentiation. This interaction is already well known to have an importance during the organ development as well as cell growth and differentiation. However, in vitro experimental model is not well developed to reproduce in vivo cellular microenvironment which provide a epithelial-mesenchymal interaction. Because conventional monolayer culture lacks epithelial-mensenchymal interaction, cultivated cells have an morphologic, biochemical, and functional characteristics differ from in vivo tissue. Moreover, it's condition is not able to induce cellular differention due to submerged culture condition. Therefore, the aims of this study were to develop and evaualte the in vitro experimental model that maintains epithelial-mesenchymal interaction by organotypic raft culture, and to characterize biologic properties of three-dimensionally reconstituted oral keratinocytes by histological and immunohistochemical analysis. The results were as follow; 1. Gingival keratinocytes reconstituted by three-dimensional organotypic culture revealed similar morphologic characteristics to biopsied patient specimen showing stratification, hyperkeratinosis, matutation of epithelial architecture. 2. Connective tissue structure was matured, and there is no difference during stratification period of epithelial 3-dimensional culture. 3. The longer of air-exposure culture on three-dimensionally reconstituted cells, the more epithelial maturation, increased epithelial thickness and surface keratinization 4. In reconstitued mucosa, the whole epidermis was positively stained by anti-involucrin antibody, and there is no difference according to air-exposured culture period. 5. The Hsp was expressed in the epithelial layer of three-dimensionally cultured cells, especially basal layer of epidermis. The change of Hsp expression was not significant by culture stratification. 6. Connexin 43, marker of cell-cell communication was revealed mild immunodeposition in reconstitued epithelium, and there is no significant expression change during stratification. These results suggest that three-dimensional oragnotypic co-culture of normal gingival keratinocytes with dermal equivalent consisting type I collagen and gingival fibroblasts results in similar morphologic and immunohistochemical characteristics to in vivo patient specimens. And this culture system seems to provide adequate micro-environment for in vitro tissue reconstitution. Therefore, further study will be focused to study of in vitro gingivitis model, development of novel perioodntal disease therapeutics and epithelial-mensenchymal interaction.
Cells, Cultured
;
Cellular Microenvironment
;
Coculture Techniques
;
Collagen Type I
;
Connective Tissue
;
Connexin 43
;
Epidermis
;
Epithelium
;
Fibroblasts*
;
Gingivitis
;
Humans
;
Keratinocytes*
;
Models, Theoretical
;
Mucous Membrane
8.Generation of monoclonal antibodies reactive to human interleukin 2(IL 2).
Youn Mun HA ; Jun Hyung LEE ; Seung Min YOO ; Jeong Je CHO ; Soon Tae HO ; Jae Kyung PARK ; Sang Yun NAM
Journal of the Korean Society for Microbiology 1993;28(4):313-319
No abstract available.
Antibodies, Monoclonal*
;
Humans*
;
Interleukins*
9.The efficacy of sevolflurane inhalation alone or its combination with intravenous remifentanil against withdrawal movements on rocuronium injection in children.
Yun Chan NA ; Hyung Gon LEE ; Seong Heon LEE ; Eun A JANG ; Myung Ha YOON
Korean Journal of Anesthesiology 2014;67(6):373-377
BACKGROUND: The aims of this study were to compare the efficacy of sevoflurane inhalation alone, intravenous remifentanil alone, and the combination of sevoflurane inhalation and remifentanil as pretreatment for the prevention of rocuronium-induced withdrawal movement in pediatric patients. METHODS: In this prospective, randomized study, 90 American Society of Anesthesiologists physical status I or II pediatric patients aged 3 to 10 years were randomly allocated to one of three treatment groups: The Group S comprising the patients receiving sevoflurane inhalation, the Group R comprising those doing intravenous remifentanil 0.5 microg/kg and the Group C comprising those doing sevoflurane inhalation+intravenous remifentanil 0.5 microg/kg. The response of the patients was graded based on a 4-point scale. RESULTS: The overall incidence of withdrawal movement on rocuronium injection was 54% (16/30) in the Group S, 57% (17/30) in the Group R and 17% (5/30) in the Group C. There was no significant difference in the incidence of withdrawal movements on rocuronium injection between the Group S and Group R. In addition, the incidence of withdrawal movements and generalized movement on rocuronium injection was significantly lower in the Group C as compared with the Group S and R (P < 0.05). CONCLUSIONS: Our results indicate not only that there was no significant difference in the degree of the effect in lowering the incidence of withdrawal movements on rocuronium injection between sevoflurane inhalation and intravenous remifentanil but also that it was significantly higher when combined with intravenous remifentanil as compared with the single use of sevoflurane inhalation or intravenous remifentanil.
Child*
;
Humans
;
Incidence
;
Inhalation*
;
Pediatrics
;
Prospective Studies
10.A Case of Sjogrens Syndrome with Multiple Bullae Secondary to Pulmonary Amyloidosis and Lymphocytic Infiltration of Interstitium and Bronchioles.
Dong Il KIM ; Yun Jeong LIM ; Yung Ha OH ; Hyung Soo KIM ; Jin Sung LEE ; Dong Soon KIM
Tuberculosis and Respiratory Diseases 1997;44(6):1426-1432
Sjogren's syndrome(SS) is a chronic inflammatory disorder characterized by lymphocytic infiltration of lacrimal and sailvary glands, which results in dry eyes and dry mouth. SS may exist as a secondary condition or as a secondary condition in association with connective tissue disease such as rheumatoid arthritis, systemic lupus erythematosus, or progressive systemic sclerosis. We experienced a patient with primary SS who developed multiple bullae, nodular type of pulmonary amyloidosis and lymphocytic interstitial peumonitis. We believe this to be the first reported case of SS acompanied by these three types pulmonary manifestations at the same time.
Amyloidosis*
;
Arthritis, Rheumatoid
;
Bronchioles*
;
Connective Tissue Diseases
;
Humans
;
Lupus Erythematosus, Systemic
;
Mouth
;
Scleroderma, Diffuse
;
Sjogren's Syndrome*